Additionally, other inpatient clinical studies reported liver dysfunctions associated with low serum albumin levels as a drawback of long-term AD when compared with control patients (Zuccalà et al. 2005b; Cattin et al. 1997b; Kim et al. 2020). This evidence concerns the gene ALB and Alzheimer disease.